ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In the light of clinical data and stem cell tests, it remains to be established whether the persistency of residual BCRABL-expressing stem cells (cycling or quiescent) in CML patients in sustained UMRD represents or not a potential risk of disease recurrence.